RSCM
APLT

Rock Springs Capital Management’s Applied Therapeutics APLT Stock Holding History

Rock Springs Capital Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,075,991
Closed -$1.26M – 101
2025
Q3 		$1.26M Hold
2,075,991
– – 0.07% 82
2025
Q2 		$646K Buy
2,075,991
+1,100
+0.1% +$426 0.04% 85
2025
Q1 		$1.01M Buy
2,074,891
+157,700
+8% +$92.9K 0.06% 88
2024
Q4 		$1.64M Buy
1,917,191
+170,742
+10% +$1.07M 0.06% 93
2024
Q3 		$14.8M Buy
1,746,449
+191,445
+12% +$1.13M 0.48% 56
2024
Q2 		$7.26M Buy
1,555,004
+57,086
+4% +$270K 0.22% 76
2024
Q1 		$10.2M Buy
1,497,918
+602,723
+67% +$2.71M 0.26% 78
2023
Q4 		$3M Buy
895,195
+86,386
+11% +$215K 0.07% 90
2023
Q3 		$2.01M Buy
808,809
+28,018
+4% +$46.2K 0.05% 100
2023
Q2 		$999K Hold
780,791
– – 0.02% 115
2023
Q1 		$633K Buy
780,791
+184,111
+31% +$181K 0.02% 117
2022
Q4 		$453K Sell
596,680
-105,000
-15% -$83K 0.01% 118
2022
Q3 		$653K Hold
701,680
– – 0.02% 124
2022
Q2 		$665K Hold
701,680
– – 0.02% 128
2022
Q1 		$1.48M Hold
701,680
– – 0.04% 127
2021
Q4 		$6.28M Hold
701,680
– – 0.15% 111
2021
Q3 		$11.6M Hold
701,680
– – 0.24% 101
2021
Q2 		$14.6M Hold
701,680
– – 0.29% 93
2021
Q1 		$13.2M Buy
701,680
+65,843
+10% +$1.42M 0.29% 93
2020
Q4 		$14M Sell
635,837
-355,736
-36% -$7.41M 0.3% 97
2020
Q3 		$20.6M Hold
991,573
– – 0.52% 62
2020
Q2 		$35.8M Buy
991,573
+145,873
+17% +$6.1M 0.98% 41
2020
Q1 		$27.6M Buy
845,700
+825,385
+4,063% +$33.4M 1.14% 34
2019
Q4 		$554K Buy
+20,315
New +$348K 0.02% 128

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Rock Springs Capital Management's APLT Position: Q4 2025 in Review

Rock Springs Capital Management sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 2,075,991 shares — an estimated $1.26M sold.

Rock Springs Capital Management first reported a position in APLT in Q4 2019 and held it in 24 quarters. The position peaked at $35.8M in Q2 2020. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

  • Rock Springs Capital Management reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Rock Springs Capital Management sold 2,075,991 Applied Therapeutics shares in Q4 2025, an estimated $1.26M.
  • Rock Springs Capital Management first reported a position in Applied Therapeutics in Q4 2019 and held it in 24 quarters.
  • Rock Springs Capital Management's Applied Therapeutics position peaked at $35.8M in Q2 2020.
  • 52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on Rock Springs Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.